NCT02848300View on ClinicalTrials.gov

Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Androgenetic Alopecia
Interventions
DRUG

Bimatoprost 1% Formulation A

Bimatoprost 1% Formulation A solution applied to the scalp and trunk once daily for 14 days.

DRUG

Bimatoprost 1% Formulation B

Bimatoprost 1% Formulation B solution applied to the scalp and trunk once daily for 14 days.

Trial Locations (1)

78759

DermResearch, LLC, Austin

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY